{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:05:39Z","timestamp":1790697939015,"version":"4.1.0"},"reference-count":32,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of VitreoRetinal Diseases"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:p>\n                    <jats:bold>Purpose:<\/jats:bold>\n                    To evaluate the prevalence of geographic atrophy (GA) lesions in patients with a diagnosis of intermediate age-related macular degeneration (iAMD).\n                    <jats:bold>Methods:<\/jats:bold>\n                    A retrospective cross-sectional study was performed of patients with an International Classification of Diseases, 10th Revision, diagnosis of iAMD. The primary outcome was the percentage of eyes diagnosed with iAMD with an undocumented GA lesion identified on imaging. Multiple logistic regression was used to assess risk factors for atrophic lesions in patients with iAMD.\n                    <jats:bold>Results:<\/jats:bold>\n                    The study included 690 eyes of 428 patients with a diagnosis of iAMD. The mean age was 79.4\u2009\u00b1\u20098.4 years, and 66.3% of patients were women. Forty-nine eyes (7.1%) were graded as having GA lesions, and 34% of these eyes had foveal involvement. The mean visual acuity (VA) was better in patients without GA lesions than in patients with GA lesions (72.9\u2009\u00b1\u200912.9 letters vs 66.4\u2009\u00b1\u200913.8 letters;\n                    <jats:italic toggle=\"yes\">P\u2009=<\/jats:italic>\n                    \u2009.001). No systemic comorbidity was associated with an increased risk for GA lesions in this cohort.\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    A notable proportion of eyes diagnosed with iAMD by eye care providers had underlying GA lesions in this real-world cohort. The use of optical coherence tomography as an adjunctive tool helped increase the detection of early GA in these patients.\n                  <\/jats:p>","DOI":"10.1177\/24741264241305107","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T05:40:43Z","timestamp":1735537243000},"page":"166-173","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Detection of Geographic Atrophy Guided by Optical Coherence Tomography Sub-RPE Illumination Analysis in Patients With Intermediate Age-Related Macular Degeneration"],"prefix":"10.1177","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0862-9068","authenticated-orcid":false,"given":"Andrei","family":"Szigiato","sequence":"first","affiliation":[{"name":"Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Maatouk","sequence":"additional","affiliation":[{"name":"Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA"},{"name":"Case Western Reserve University School of Medicine, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander E.","family":"Azar","sequence":"additional","affiliation":[{"name":"Case Western Reserve University School of Medicine, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Alsaloum","sequence":"additional","affiliation":[{"name":"Case Western Reserve University School of Medicine, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Talcott","sequence":"additional","affiliation":[{"name":"Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi P.","family":"Singh","sequence":"additional","affiliation":[{"name":"Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA"},{"name":"Cleveland Clinic Martin Hospitals, Cleveland Clinic Florida, Stuart, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7725-1631","authenticated-orcid":false,"given":"Aleksandra V.","family":"Rachitskaya","sequence":"additional","affiliation":[{"name":"Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,12,30]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(17)30393-5"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.11.023"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)90340-8"},{"key":"e_1_3_2_5_2","unstructured":"FDA US Food and Drug Administration. NDA Approval. Published 2023. Accessed May 20 2023. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2023\/217171Orig1s000ltr.pdf"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.07.011"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2009.11.003"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2021.1407"},{"key":"e_1_3_2_9_2","first-page":"2023","article-title":"Phase 3 DERBY and OAKS clinical trials for geographic atrophy","volume":"2023","author":"Singh R","unstructured":"Singh R. Phase 3 DERBY and OAKS clinical trials for geographic atrophy. In: Angiogenesis, Exudation, and Degeneration 2023; 2023.","journal-title":"Angiogenesis, Exudation, and Degeneration"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01583-0"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.04.015"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.08.018"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.3928\/23258160-20130313-05"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","DOI":"10.3928\/15428877-20080715-01","article-title":"Spectral domain optical coherence tomographic imaging of geographic atrophy","volume":"39","author":"Lujan B","year":"2008","unstructured":"Lujan B, Rosenfeld P, Gregori G, et al. Spectral domain optical coherence tomographic imaging of geographic atrophy. Ophthalmic Surg Lasers Imaging. 2008;39:S8-S14.","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2022.03.017"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2023.03.012"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.3928\/23258160-20230223-01"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.09.028"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2021.03.008"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjo.2021.01.005"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1159\/000510507"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2020.03.020"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.61.1.2"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2023.05.004"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.3928\/23258160-20150422-03"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2022.11.012"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2023.03.011"},{"key":"e_1_3_2_28_2","first-page":"912","article-title":"Accuracy and completeness of clinical coding using ICD-10 for ambulatory visits","volume":"2017","author":"Horsky J","year":"2017","unstructured":"Horsky J, Drucker EA, Ramelson HZ. Accuracy and completeness of clinical coding using ICD-10 for ambulatory visits. AMIA Annu Symp Proc. 2017;2017:912-920.","journal-title":"AMIA Annu Symp Proc"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S367089"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-023-02497-w"},{"key":"e_1_3_2_31_2","unstructured":"ClinicalTrials.gov. EXPLORE: a phase II study to evaluate the safety and efficacy of two doses of GT005. ClinicalTrials.gov Identifier: NCT04437368. Accessed June 4 2023. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04437368"},{"key":"e_1_3_2_32_2","unstructured":"ClinicalTrials.gov. HORIZON: a Phase II study to evaluate the safety and efficacy of two doses of GT005. ClinicalTrials.gov Identifier: NCT04566445. Accessed June 4 2023. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04566445"},{"key":"e_1_3_2_33_2","unstructured":"ClinicalTrials.gov. Safety and efficacy study of OpRegen for treatment of advanced dry-form age-related macular degeneration. ClinicalTrials.gov Identifier: NCT02286089. https:\/\/clinicaltrials.gov\/study\/NCT02286089?term=NCT02286089&rank=1"}],"container-title":["Journal of VitreoRetinal Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/24741264241305107","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/24741264241305107","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/24741264241305107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:24:39Z","timestamp":1790695479000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/24741264241305107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,30]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1177\/24741264241305107"],"URL":"https:\/\/doi.org\/10.1177\/24741264241305107","relation":{},"ISSN":["2474-1264","2474-1272"],"issn-type":[{"value":"2474-1264","type":"print"},{"value":"2474-1272","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,30]]}}}